Skip to main content
Watch Insiders
ANROHealthcare

Alto Neuroscience Inc (ANRO) Insider Trading

In the last 90 days, 1 Alto Neuroscience Inc (ANRO) insider reported no open-market purchases and 1 sale totaling $3,567,249. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Sep 30, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Sep 30, 2026Nicholas Conrad SmithPRESIDENT AND CFOSale134,886$26.45$3,567,249

Common questions

ANRO insider trading FAQ

Are ANRO insiders buying or selling?
Over the last 90 days, ANRO insiders were net sellers, reporting $0.00 of open-market purchases and $3,567,249 of sales.
When was the last ANRO insider purchase?
No open-market insider purchase of Alto Neuroscience Inc stock was reported in the last 90 days.
Where does ANRO insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Alto Neuroscience Inc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.